What is Norac Pharma?
Norac Pharma operates as a premier contract development and manufacturing organization (CDMO) specializing in process research and development (R&D) and the supply of active pharmaceutical ingredients (APIs). The company provides a comprehensive suite of services, encompassing API R&D, analytical R&D, API manufacturing, and preclinical support, all facilitated by advanced, state-of-the-art facilities.
Renowned for its unwavering commitment to environmental, health, and safety (EHS) standards, Norac Pharma has been recognized with accolades such as the SOCMA National Performance Improvement Honor. The company actively partners with pharmaceutical firms seeking innovative chemistry solutions and dependable API sourcing, positioning itself as a critical player in the drug development ecosystem.
How much funding has Norac Pharma raised?
Norac Pharma has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
What's next for Norac Pharma?
The recent major strategic investment signals Norac Pharma's readiness for an accelerated growth phase, likely focused on expanding its R&D capabilities, enhancing manufacturing capacity, and potentially broadening its service offerings. This capital injection is expected to fortify its competitive edge in the pharmaceutical supply chain, enabling the company to pursue new market opportunities and deepen existing client relationships.
Given the enterprise-level context of its funding, Norac Pharma is poised to scale its operations significantly, further solidifying its role as a key partner for pharmaceutical companies navigating complex drug development pathways and API procurement.
